Literature DB >> 9626054

Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+.

M Goggins1, G J Offerhaus, W Hilgers, C A Griffin, M Shekher, D Tang, T A Sohn, C J Yeo, S E Kern, R H Hruban.   

Abstract

The clinical and pathological features of carcinomas of the pancreas with DNA replication errors (RER+) have not been characterized. Eighty-two xenografted carcinomas of the pancreas were screened for DNA replication errors using polymerase chain reaction amplification of microsatellite markers. Cases with microsatellite instability in at least two markers of a minimum of five tested were considered RER+. RER status was correlated with histological appearance, karyotype of the carcinomas when available, K-ras mutational status, and patient outcome. Three (3.7%) of the eighty-two carcinomas were RER+. In contrast to typical gland-forming adenocarcinomas of the pancreas, all three RER+ carcinomas were poorly differentiated and had expanding borders and a prominent syncytial growth pattern. Neither a Crohn's-like lymphoid infiltrate nor extracellular mucin production were prominent. Ductal adenocarcinomas of the pancreas typically contain a mutant K-ras gene, yet all three RER+ carcinomas had wild-type K-ras. One of the three RER+ carcinomas was karyotyped and showed a near diploid pattern. All three of the RER+ tumors were removed via Whipple resection. One of the three patients is free of disease 16 months after pancreaticoduodenectomy, one is alive and free of tumor at 52 months but developed two colon carcinomas during this period, and the third died of pancreatic cancer at 4 months. None of the three patients had a family history of colorectal carcinoma. A review of the K-ras wild-type carcinomas in a previously characterized series of pancreatic carcinomas with known K-ras mutational status identified two additional cancers with poor differentiation, a syncytial growth pattern, and pushing borders. Both of the cancers were diploid and both patients were longterm survivors (over 5 years). The inclusion of such patients in previous prognostic studies of pancreas cancer may explain the failure of histological grade to be a predictor of prognosis. These data suggest that DNA replication errors occur in a small percentage of resected carcinomas of the pancreas and that wild-type K-ras gene status and a medullary phenotype characterized by poor differentiation, and expanding pattern of invasion, and syncytial growth should suggest the possibility of DNA replication errors in carcinomas of the pancreas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9626054      PMCID: PMC1858440     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Tumor-suppressive pathways in pancreatic carcinoma.

Authors:  E Rozenblum; M Schutte; M Goggins; S A Hahn; S Panzer; M Zahurak; S N Goodman; T A Sohn; R H Hruban; C J Yeo; S E Kern
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

2.  Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred.

Authors:  Y Akiyama; H Sato; T Yamada; H Nagasaki; A Tsuchiya; R Abe; Y Yuasa
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

Review 3.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

Authors:  W Burke; G Petersen; P Lynch; J Botkin; M Daly; J Garber; M J Kahn; A McTiernan; K Offit; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

4.  Microsatellite instability-associated mutations associate preferentially with the intestinal type of primary gastric carcinomas in a high-risk population.

Authors:  Y J Chung; J M Song; J Y Lee; Y T Jung; E J Seo; S W Choi; M G Rhyu
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

5.  Allelotype of pancreatic adenocarcinoma using xenograft enrichment.

Authors:  S A Hahn; A B Seymour; A T Hoque; M Schutte; L T da Costa; M S Redston; C Caldas; C L Weinstein; A Fischer; C J Yeo
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

6.  Microsatellite instability in endometrial carcinomas: frequent replication errors in tumors of early onset and/or of poorly differentiated type.

Authors:  K Kobayashi; S Sagae; R Kudo; H Saito; S Koi; Y Nakamura
Journal:  Genes Chromosomes Cancer       Date:  1995-10       Impact factor: 5.006

7.  Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis.

Authors:  N R dos Santos; R Seruca; M Constância; M Seixas; M Sobrinho-Simões
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

8.  Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile.

Authors:  R Seruca; N R Santos; L David; M Constância; H Barroca; F Carneiro; M Seixas; P Peltomäki; R Lothe; M Sobrinho-Simões
Journal:  Int J Cancer       Date:  1995-02-20       Impact factor: 7.396

Review 9.  Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch Syndrome).

Authors:  H T Lynch; T Smyrk; J F Lynch
Journal:  Int J Cancer       Date:  1996-02-20       Impact factor: 7.396

10.  Microsatellite instability in transitional cell carcinoma of the urinary tract and its relationship to clinicopathological variables and smoking.

Authors:  T Uchida; C Wang; C Wada; M Iwamura; S Egawa; K Koshiba
Journal:  Int J Cancer       Date:  1996-04-22       Impact factor: 7.396

View more
  70 in total

1.  Inherited predisposition to pancreatic cancer.

Authors:  E Efthimiou; T Crnogorac-Jurcevic; N R Lemoine; T A Brentnall
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

Review 2.  Molecular signatures of pancreatic cancer.

Authors:  Seung-Mo Hong; Jason Y Park; Ralph H Hruban; Michael Goggins
Journal:  Arch Pathol Lab Med       Date:  2011-06       Impact factor: 5.534

Review 3.  Update on familial pancreatic cancer.

Authors:  H T Lynch; R E Brand; C A Deters; R M Fusaro
Journal:  Curr Gastroenterol Rep       Date:  2001-04

4.  A woman with remotely treated pancreas cancer and new abdominal pain: a discussion of evaluation and management.

Authors:  Andrew S Epstein; Eileen M O'Reilly; Maeve Lowery; Ali Shamseddine; Jinru Shia; Sally Temraz; Ashwaq Al-Olayan; Mohamed Naghy; David Kelsen; Manish A Shah; Ghassan K Abou-Alfa
Journal:  J Gastrointest Cancer       Date:  2011-12

Review 5.  Hereditary pancreatic cancer.

Authors:  Shilpa Grover; Sapna Syngal
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

Review 6.  Current progress in immunotherapy for pancreatic cancer.

Authors:  Kelly Foley; Victoria Kim; Elizabeth Jaffee; Lei Zheng
Journal:  Cancer Lett       Date:  2015-12-23       Impact factor: 8.679

7.  [Ulcerating tumor in the duodenum and head of the pancreas].

Authors:  W Wild; G Mall; T Balci; P Hödl; P Dörr; M H M Schwarzbach
Journal:  Chirurg       Date:  2013-12       Impact factor: 0.955

Review 8.  Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine.

Authors:  Erik S Knudsen; Eileen M O'Reilly; Jonathan R Brody; Agnieszka K Witkiewicz
Journal:  Gastroenterology       Date:  2015-09-15       Impact factor: 22.682

9.  Inverse relationship between APC gene mutation in gastric adenomas and development of adenocarcinoma.

Authors:  Jae-Hyuk Lee; Susan C Abraham; Hyun-Soo Kim; Jong-Hee Nam; Chan Choi; Min-Cheol Lee; Chang-Soo Park; Sang-Woo Juhng; Asif Rashid; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 10.  Pancreatic carcinogenesis.

Authors:  Jan-Bart M Koorstra; Steven R Hustinx; G Johan A Offerhaus; Anirban Maitra
Journal:  Pancreatology       Date:  2008-04-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.